[Retracted] Development of Microneedle Patch Loaded with <i>Bacopa monnieri</i> Solid Lipid Nanoparticles for the Effective Management of Parkinson’s Disease

<div> Histopathology studies: (a) disease control; (b) standard (pure drug patch); (c) test 1 (blank SLN patch); (d) test 2 (blank patch); (e) test 3 (drug+SLN patch). The ratio of TDC: total number of degenerative neuronal cells; TNC: total number of normal neuronal cells. TDC: TNC for the disease control group, 5.53:1; standard: 1:1.705; test 1: 1:2.21; test 2: 1.08:1; test 3: 1:4.5.</div>

Bioinorganic Chemistry and Applications

fig13

Figure 13

Figure 13: [Retracted] Development of Microneedle Patch Loaded with <i>Bacopa monnieri</i> Solid Lipid Nanoparticles for the Effective Management of Parkinson’s Disease 

Figure 13 | [Retracted] Development of Microneedle Patch Loaded with Bacopa monnieri Solid Lipid Nanoparticles for the Effective Management of Parkinson’s Disease 